Symetrique Decision-Grade Evidence

Market Research Built on RWD and Global Disease Intelligence

A stronger foundation for market sizing, segmentation, and forecasting Across pharma, diagnostics, and medical devices.

Symetrique helps healthcare companies build a more accurate view of market opportunity by combining real-world data, global epidemiology, disease-state context, and targeted primary research. Instead of relying primarily on small-sample surveys and interviews, we use claims, EHR, registries, public health datasets, prevalence and incidence sources, standards-of-care research, and real-world utilization patterns to create a more grounded and defensible understanding of the market. Our approach is especially valuable when the goal is to understand the true size of the opportunity, the structure of the treated and untreated market, the variation across geographies and care settings, and the likely evolution of demand before and after launch.

Why a Different Approach Is Needed

Traditional healthcare market research often depends heavily on sample-based surveys and interviews. While these methods offer valuable perceptual insights, they can provide a narrow window into true market opportunity when used as the primary foundation for sizing and forecasting.

  • Data-Driven Foundation: Real-world data provides empirical grounding beyond survey sample bias
  • Global Perspective: Prevalence and incidence datasets expand understanding across geographies and care settings
  • Clinical Context: Standards-of-care research illuminates treatment pathways and decision logic
  • Validated Intelligence: Primary research selectively refines rather than independently defines market understanding

What Makes Symetrique Different

Symetrique uniquely combines the empirical power of real-world data with expert market interpretation. We integrate global datasets—claims, EHR, registries, epidemiology, public health sources—with standards-of-care research and targeted primary insights to deliver market intelligence that is comprehensive, contextual, and strategically defensible.

  • Real-World Data Foundation: Observed utilization, diagnosis patterns, and progression trends grounded in actual patient behavior
  • Global Disease Intelligence: Prevalence, incidence, and burden-of-disease data to understand true market opportunity
  • Clinical Market Context: Standards of care, treatment pathways, and expert interpretation that make data meaningful
  • Decision-Ready Intelligence: Market size, segmentation, opportunities, and forecast scenarios tailored for strategic and commercial decisions

Contextual Insights

In market research, context matters as much as the dataset itself. Claims, EHR, registries, epidemiology sources, and public health datasets can show market shape and utilization patterns, but they do not automatically explain treatment logic, local care pathways, policy variation, or how disease management differs across countries and systems. Symetrique adds a contextual insight layer that combines data interpretation with disease-state knowledge, standards-of-care research, protocol review, external literature, and targeted primary research.

  • Internal and external data assets interpreted in disease-state context
  • Standards-of-care, protocols, and treatment pathway research to explain market structure
  • Primary research used to refine assumptions, not replace the data foundation
  • Continuous refinement of market models as new evidence, publications, and market signals emerge

Use Cases

Symetrique's market research methodology is suited to a wide range of strategic and commercial planning scenarios across the healthcare industry.

  • Pre-clinical and early pipeline market opportunity estimation
  • Pre-launch and launch market sizing
  • Existing product market reassessment
  • Comparative sizing across indications or competitors
  • Geographic and regional opportunity mapping
  • Treated vs untreated population assessment
  • Scenario-based demand forecasting
  • Diagnostics and device market opportunity modeling